SOTIO Biotech Alternatives & Competitors
12 companies similar to SOTIO Biotech — Shaping the future of cancer immunotherapies by translating compelling science i...
Companies similar to SOTIO Biotech
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
Celularity Inc.
A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectiou...
United States
-logo.jpg "VBL Therapeutics (Nasdaq:VBLT)"){kind=logo}
VBL Therapeutics (Nasdaq:VBLT)
Engineering the future of targeted medicines, breaking barriers to develop the next genera...
Israel
Rival Readout
Competing with SOTIO Biotech? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Sensei Bio
We follow the immune system’s teachings to discover new treatments that inspire the body t...
Rockville, United States
Asylia Therapeutics
Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...
Abcuro, Inc
Developing immunotherapies for autoimmune diseases and cancer
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
ImmunGene
Innovation in antibody-cytokine fusion technology and monoclonal antibody-based therapies...
PDC*line Pharma
A novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid...
Liege, Belgium
Biond Biologics Ltd
Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics f...
Israel
Minerva Biotechnologies
We see the future first
Waltham, United States
About SOTIO Biotech
SOTIO Biotech is a Czech Republic-based biotechnology company, established in 2010. The company's slogan "Shaping the future of cancer immunotherapies by translating compelling science into patient benefit" reflects its core mission. SOTIO Biotech is focused on translating scientific breakthroughs into tangible patient...
Cancer Immunotherapies, Biotech, Clinical Pipeline, PD-1-inhibiting Cytokine, CAR T Therapies, Antibody-drug Conjugates, PPF Group, Research & Development, Collaborations, In-licensing, Investments, Mergers, Active Cellular Immunotherapy, Dendritic Cells, Autoimmune Diseases
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around SOTIO Biotech: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at SOTIO Biotech on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 11 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
